Business Description
Actinogen Medical Ltd
SIC : 2836
ISIN : AU000000ACW3
Compare
Compare
Traded in other countries / regions
ACW.Australia3AC.GermanyATGGF.USA IPO Date
2007-10-19Description
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 254.93 | |||||
| Equity-to-Asset | 0.85 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -14.5 | |||||
| 3-Year EPS without NRI Growth Rate | -6.3 | |||||
| 3-Year FCF Growth Rate | -35.7 | |||||
| 3-Year Book Growth Rate | -8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.19 | |||||
| 9-Day RSI | 47.01 | |||||
| 14-Day RSI | 47.04 | |||||
| 6-1 Month Momentum % | 70 | |||||
| 12-1 Month Momentum % | -28.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.42 | |||||
| Quick Ratio | 5.42 | |||||
| Cash Ratio | 5.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.8 | |||||
| Shareholder Yield % | -14.03 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -107.61 | |||||
| ROA % | -94.54 | |||||
| ROIC % | -566.12 | |||||
| ROC (Joel Greenblatt) % | -14327.65 | |||||
| ROCE % | -107.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5.8 | |||||
| EV-to-EBIT | -3.78 | |||||
| EV-to-EBITDA | -3.9 | |||||
| EV-to-Forward-EBITDA | -1.59 | |||||
| EV-to-Forward-Revenue | 2.76 | |||||
| EV-to-FCF | -4.46 | |||||
| Price-to-Net-Current-Asset-Value | 1.7 | |||||
| Earnings Yield (Greenblatt) % | -26.42 | |||||
| FCF Yield % | -18.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Actinogen Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.004 | ||
| Beta | 4.6 | ||
| Volatility % | 111.16 | ||
| 14-Day RSI | 47.04 | ||
| 14-Day ATR (€) | 0.000661 | ||
| 20-Day SMA (€) | 0.01715 | ||
| 12-1 Month Momentum % | -28.65 | ||
| 52-Week Range (€) | 0.0075 - 0.029 | ||
| Shares Outstanding (Mil) | 2,326.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Actinogen Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Actinogen Medical Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Actinogen Medical Ltd Frequently Asked Questions
What is Actinogen Medical Ltd(FRA:3AC)'s stock price today?
The current price of FRA:3AC is €0.02. The 52 week high of FRA:3AC is €0.03 and 52 week low is €0.01.
When is next earnings date of Actinogen Medical Ltd(FRA:3AC)?
The next earnings date of Actinogen Medical Ltd(FRA:3AC) is .
Does Actinogen Medical Ltd(FRA:3AC) pay dividends? If so, how much?
Actinogen Medical Ltd(FRA:3AC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers